These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 920936)

  • 21. N-hydroxylation of the carcinogen 2-acetylaminofluorene by rabbit-liver microsomes.
    IRVING CC
    Biochim Biophys Acta; 1962 Dec; 65():564-6. PubMed ID: 13956723
    [No Abstract]   [Full Text] [Related]  

  • 22. Separation and quantitative determination of 2-acetyl-aminofluorene and its hydroxylated metabolites by high pressure liquid chromatography.
    Thorgeirsson SS; Nelson WL
    Anal Biochem; 1976 Sep; 75(1):122-8. PubMed ID: 962123
    [No Abstract]   [Full Text] [Related]  

  • 23. Microsomal metabolism of the carcinogen, N-2-fluorenylacetamide, by the mammary gland and liver of female rats. I. Ring- and N-hydroxylations of N-2-fluorenylacetamide.
    Malejka-Giganti D; Decker RW; Ritter CL; Polovina MR
    Carcinogenesis; 1985 Jan; 6(1):95-103. PubMed ID: 3967341
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pseudoenzymatic reduction of N-hydroxy-2-acetylaminofluorene to 2-acetylaminofluorene mediated by cytochrome P450.
    Kitamura S; Takekawa K; Sugihara K; Tatsumi K; Ohta S
    Carcinogenesis; 1999 Feb; 20(2):347-50. PubMed ID: 10069476
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Absorption and protein binding of N-2-fluorenylacetamide and its metabolites in the bladder of rabbit.
    Hopp ML; Matsumoto M; Lee C; Oyasu R
    J Natl Cancer Inst; 1977 Feb; 58(2):281-5. PubMed ID: 833876
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metabolism and activation of 2-acetylaminofluorene in isolated rat hepatocytes.
    Dybing E; Søderlund E; Haug LT; Thorgeirsson SS
    Cancer Res; 1979 Aug; 39(8):3268-75. PubMed ID: 455309
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel oxidation of the carcinogen N-hydroxy-N-2-fluorenylacetamide catalyzed by peroxidase/H2O2/Br-.
    Ritter CL; Malejka-Giganti D
    Biochem Biophys Res Commun; 1985 Aug; 131(1):174-81. PubMed ID: 4038295
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reduction of N-hydroxy-2-acetylaminofluorene by liver microsomes.
    Yamazoe Y; Ishii K; Yamaguchi N; Kamataki T; Kato R
    Biochem Pharmacol; 1980 Aug; 29(16):2183-8. PubMed ID: 7426024
    [No Abstract]   [Full Text] [Related]  

  • 29. ENZYMATIC N-HYDROXYLATION OF THE CARCINOGEN 2-ACETYLAMINOFLUORENE AND THE METABOLISM OF N-HYDROXY-2-ACETYLAMINOFLUORENE-9-14C IN VITRO.
    IRVING CC
    J Biol Chem; 1964 May; 239():1589-96. PubMed ID: 14193833
    [No Abstract]   [Full Text] [Related]  

  • 30. Activation of the O-glucuronide of the carcinogen N-hydroxy-N-2-fluorenylacetamide by enzymatic deacetylation in vitro: formation of fluorenylamine-tRNA adducts.
    Cardona RA; King CM
    Biochem Pharmacol; 1976 May; 25(9):1051-6. PubMed ID: 5097
    [No Abstract]   [Full Text] [Related]  

  • 31. Growth of various bacteria on polycyclic aromatic hydrocarbons and N-2-fluorenylacetamide.
    Martinsen CS; Zachariah PK
    J Appl Bacteriol; 1978 Jun; 44(3):365-71. PubMed ID: 670110
    [No Abstract]   [Full Text] [Related]  

  • 32. Genetic differences in the enzymic properties of the aromatic hydrocarbon inducible N-hydroxylation of 2-acetylaminofluorene in mouse liver.
    Razzouk C; Batardy-Grégoire M; Roberfroid M
    Carcinogenesis; 1982; 3(11):1325-9. PubMed ID: 7151250
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activation of certain N-arylacetamides and N-arylacetohydroxamic acids in relation to mammary gland tumorigenesis in the rat.
    Malejka-Giganti D
    Natl Cancer Inst Monogr; 1981 Dec; (58):69-77. PubMed ID: 6804871
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biological implications of the reaction possibilities of the proximate carcinogenic compound, N-hydroxy-2-fluorenylacetamide.
    Lhoëst G; Razzouk C; Mercier M
    Biomed Mass Spectrom; 1976 Feb; 3(1):21-7. PubMed ID: 1260112
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sulfation of N-hydroxy-2-acetylaminofluorene in normal and nodular liver from male Wistar rats.
    Blanck A; Wicksell L; Eriksson LC
    Toxicol Pathol; 1987; 15(1):103-5. PubMed ID: 3576071
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of detergents on the N-and ring-hydroxylation of 2-acetamidofluorene by hamster liver microsomal preparations.
    Lotlikar PD; Dwyer EN
    Biochem J; 1976 Dec; 160(3):821-4. PubMed ID: 1016257
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The deacetylation of N-hydroxy-2-acetylaminofluorene by rat liver microsomes and carboxyl esterase.
    Steward JE; Floyd RA
    Cancer Biochem Biophys; 1980; 5(1):47-53. PubMed ID: 6260332
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Species difference in liver microsomal and cytosolic enzymes involved in mutagenic activation of N-hydroxy-N-2-fluorenylacetamide.
    Kaneda S; Seno T; Takeishi K
    J Natl Cancer Inst; 1981 Sep; 67(3):549-55. PubMed ID: 6944527
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metabolism of 2-acetylaminofluorene in cultured human lymphocytes.
    McManus ME; Trainor KJ; Morley AA; Burgess W; Stupans I; Birkett DJ
    Res Commun Chem Pathol Pharmacol; 1987 Mar; 55(3):409-18. PubMed ID: 3575877
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Microsomal metabolism of the carcinogen, N-2-fluorenyl-acetamide, by the mammary gland and liver of female rats. II. Glucuronidation of ring- and N-hydroxylated metabolites of N-2-fluorenylacetamide.
    Malejka-Giganti D; Ryzewski CN
    Carcinogenesis; 1985 May; 6(5):687-92. PubMed ID: 3924428
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.